ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $178,000 | +134.2% | 126,000 | +100.0% | 0.01% | +40.0% |
Q2 2020 | $76,000 | +2.7% | 63,000 | 0.0% | 0.01% | -16.7% |
Q1 2020 | $74,000 | -44.4% | 63,000 | 0.0% | 0.01% | -36.8% |
Q4 2019 | $133,000 | -4.3% | 63,000 | 0.0% | 0.02% | -17.4% |
Q3 2019 | $139,000 | -12.6% | 63,000 | 0.0% | 0.02% | -39.5% |
Q2 2019 | $159,000 | – | 63,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
LMR Partners LLP | 148,309 | $319,000 | 0.02% |
LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |